iMedic.health

Immunomodulator (multiple sclerosis): Class Overview and Comparison

Quick answer: Immunomodulator (multiple sclerosis) are a class of medicines used for specific therapeutic indications. iMedic covers 2 immunomodulator (multiple sclerosis) substances. Below is a comparison table linking to detailed pages for each.

Immunomodulator (multiple sclerosis) on iMedic (2 substances)

Substance Primary indications Mechanism Common dose
CopaxoneRelapsing-remitting multiple sclerosisGlatiramer acetate, a synthetic polypeptide that modulates autoimmune response a20 mg subcutaneously daily or 40 mg three times weekly
GlatimylRelapsing-remitting multiple sclerosisRandom polypeptide that modulates T-cell response and shifts cytokine profile to20 mg SC daily or 40 mg SC three times weekly

About Immunomodulator (multiple sclerosis)

Immunomodulator (multiple sclerosis) share a common mechanism of action and clinical use. Specific dosing, side effects, contraindications, and drug interactions vary between individual substances within the class. Click any substance above for full prescribing information and patient guidance.

Common considerations across the class

Always consult the prescribing information for the specific medicine prescribed and discuss with your clinician.

Medical disclaimer: This tool provides educational information for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your individual situation with a qualified healthcare provider.

Frequently asked questions

What are Immunomodulator (multiple sclerosis)?

Immunomodulator (multiple sclerosis) are medicines that share a common mechanism of action used for specific therapeutic indications. iMedic currently covers 2 substances in this class with detailed pages for each.

Are all Immunomodulator (multiple sclerosis) interchangeable?

No. While medicines in the same class share a mechanism, they differ in potency, dosing, drug interactions, and tolerability. Switching between them is a clinical decision based on individual response, side effects, and treatment goals.

How do I choose between different Immunomodulator (multiple sclerosis)?

Selection depends on the specific clinical indication, patient factors (age, comorbidities, kidney/liver function, other medications), tolerability of side effects, cost, and clinician preference. This is a prescribing decision.

Are Immunomodulator (multiple sclerosis) available as generics?

Most well-established class members are available as generic alternatives, often substantially less expensive than brand-name versions while clinically equivalent. Newer members may still be brand-only.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.